Lv1
10 积分 2024-08-23 加入
Mathematical modeling predicts optimal immune checkpoint inhibitor and radiotherapy combinations and timing of administration
6小时前
待确认
Emerging evidence for adapting radiotherapy to immunotherapy
21天前
已完结
Selective Elimination of Breast Surgery for Invasive Breast Cancer
1个月前
已完结
Perioperative outcomes and survival after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma
2个月前
已完结
Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis
2个月前
已完结
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes
3个月前
已完结
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial
6个月前
已完结
Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1)
7个月前
已完结
Loco-Regional Control and Survival Outcomes After Combined Stereotactic Radiation Therapy and Immune Checkpoint Inhibitors for Brain Metastases From Non-Small Cell Lung Cancer
8个月前
已完结
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
8个月前
已完结
皖公网安备34019202002308
